Keystone Industries

Form 483 issued December 21, 2022 · Gibbstown, New Jersey

Inspection
Dec 15 – Dec 21, 2022
Observations
2
Pages
3
FEI number
3010002722

In short: On December 21, 2022, FDA issued a Form 483 with 2 observations to Keystone Industries in Gibbstown, New Jersey (FEI 3010002722) after an inspection that ran Dec 15 – Dec 21, 2022. The investigators were Juanita P. Versace and Vivin George. Most observations concern laboratory controls and quality system; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

Laboratory controls and quality system account for 2 of 2 observations.

Laboratory controls1
Quality system1

Most cited: 21 CFR 211.165(a) (1×) · 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

  2. 02

    The responsibilities and procedures applicable to the quality control unit…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Keystone Industries?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and quality system. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Keystone Industries?

Juanita P. Versace and Vivin George are named on this Form 483, for the inspection of Dec 15 – Dec 21, 2022. Each investigator has a profile showing what they cite most.

When was Keystone Industries inspected by FDA?

The inspection ran Dec 15 – Dec 21, 2022, and the Form 483 is dated December 21, 2022.

How do I get the full Form 483 for Keystone Industries?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free